LncRNA FLG-AS1 Mitigates Diabetic Retinopathy by Regulating Retinal Epithelial Cell Inflammation, Oxidative Stress, and Apoptosis via miR-380-3p/SOCS6 Axis

被引:0
作者
Rong Luo
Lan Li
Fan Xiao
Jinsong Fu
机构
[1] The First Affiliated Hospital of Nanchang Medical college,Department of ophthalmology
[2] Jiangxi Provincial People’s Hospital,undefined
来源
Inflammation | 2022年 / 45卷
关键词
diabetic retinopathy; FLG-AS1; miR-380-3p; SOCS6; inflammation; oxidative stress; apoptosis.;
D O I
暂无
中图分类号
学科分类号
摘要
The objective of this study is to investigate lncRNA FLG-AS1-mediated miR-380-3p/SOCS6 axis in inflammation, oxidative stress, and apoptosis of retinal epithelial cells in diabetic retinopathy (DR). Fasting blood was collected from 60 DR patients and 60 healthy controls. The Pearson correlation was used to analyze the correlation between the expression levels of FLG-AS1 and miR-380-3p in DR patients. qRT-PCR and/or Western blotting were used to detect the expression of FLG-AS1, miR-380-3p, and SOCS6. After gain of function of FLG-AS1 or SOCS6 or loss of function of miR-380-3p, high glucose (HG)–treated human retinal pigment epithelial ARPE-19 cells were subjected to TUNEL assessment of apoptosis. ELISA was performed to detect the expression levels of IL-1β, IL-6, and TNF-α in cell culture supernatant. DCFH-DA was used to detect the level of ROS in the cells. MDA and SOD assay kits were used to measure the activity of MDA and SOD in the cells. Dual-luciferase reporter assay was performed to verify the binding between miR-380-3p and FLG-AS1 or between miR-380-3p and SOCS6. Streptozotocin injections were used to induce diabetes in rats which were injected with FLG-AS1 overexpression lentiviral vectors in the eye. Twenty weeks later, retinal tissue was isolated and stained with hematoxylin–eosin or TUNEL. Compared to that in healthy controls, FLG-AS1 expression decreased 2.5-fold and miR-380-3p expression increased 2.6-fold in the serum of DR patients. The expression levels of FLG-AS1 and miR-380-3p were negatively correlated in DR patients (r = −0.3772, P = 0.003). Overexpression of FLG-AS1 reduced inflammation, oxidative stress, and apoptosis of HG-treated ARPE-19 cells and alleviated retinal injury in diabetic rats. FLG-AS1 promoted the expression of SOCS6 by targeting miR-380-3p. Inhibition of miR-380-3p or overexpression of SOCS6 reduced inflammation, oxidative stress, and apoptosis of HG-treated ARPE-19 cells. FLG-AS1 mitigates DR by regulating retinal epithelial cell inflammation, oxidative stress, and apoptosis via the miR-380-3p/SOCS6 axis.
引用
收藏
页码:1936 / 1949
页数:13
相关论文
共 144 条
  • [1] Gargeya R(2017)Automated Identification of Diabetic Retinopathy Using Deep Learning Ophthalmology 124 962-969
  • [2] Leng T(2016)Pathophysiology of diabetic retinopathy: The old and the new Diabetic retinopathy. Nat Rev Dis Primers 2 16012-376
  • [3] Wong TY(2018)Aflibercept, bevacizumab and ranibizumab prevent glucose-induced damage in human retinal pericytes in vitro, through a PLA2/COX-2/VEGF-A pathway Diabetes and Metabolism Journal 42 364-287
  • [4] Cheung CM(2015)Research progress of lncRNAs in diabetic retinopathy Biochemical Pharmacology 96 278-1617
  • [5] Larsen M(2021)Transcriptome analysis reveals differentially expressed lncRNAs between oral squamous cell carcinoma and healthy oral mucosa European Journal of Ophthalmology 31 1606-31531
  • [6] Sharma S(2017)Co-expression network analysis of the lncRNAs and mRNAs associated with cervical cancer progression Oncotarget 8 31521-764
  • [7] Simo R(2019)Identification of a 14-lncRNA signature and construction of a prognostic nomogram predicting overall survival of gastric cancer Archives of Medical Science 15 754-1544
  • [8] Kusuhara S(2020)The construction and analysis of the aberrant lncRNA-miRNA-mRNA network in adipose tissue from type 2 diabetes individuals with obesity DNA and Cell Biology 39 1532-1207
  • [9] Fukushima Y(2020)MicroRNA Journal of Diabetes Research 2020 3980742-2194
  • [10] Ogura S(2018)Retinal and circulating miRNA expression patterns in diabetic retinopathy: An in silico and in vivo approach The Journal of Allergy and Clinical Immunology 141 1202-1351